Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer
Salama, M., Wagieh, S., Tarek, M., El-Sayed, N. (2023). Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer. EKB Journal Management System, 26(1), 83-97. doi: 10.21608/egyjnm.2022.176520.1072
Maha Salama; Sherin Wagieh; Mirna Tarek; Nahla Dessouki El-Sayed. "Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer". EKB Journal Management System, 26, 1, 2023, 83-97. doi: 10.21608/egyjnm.2022.176520.1072
Salama, M., Wagieh, S., Tarek, M., El-Sayed, N. (2023). 'Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer', EKB Journal Management System, 26(1), pp. 83-97. doi: 10.21608/egyjnm.2022.176520.1072
Salama, M., Wagieh, S., Tarek, M., El-Sayed, N. Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer. EKB Journal Management System, 2023; 26(1): 83-97. doi: 10.21608/egyjnm.2022.176520.1072